The Effect of a Persian Herbal Medicine Compound on the Lipid Profiles of Patients with Dyslipidemia: A Randomized Double-Blind Placebo-Controlled Clinical Trial
Table 2
Comparison and changes in the lipid profile between intervention and placebo groups after 6 weeks (mean ± SD).
Parameters
Intervention group (n = 35)
Baseline placebo group (n = 36)
value
Intervention group (n = 35)
After 6 weeks placebo group (n = 36)
value
Serum cholesterol (mg/dL)
234.56 ± 7.35
227 ± 6.85
0.46
198.65 ± 6.24
222.08 ± 6.38
0.01
HDL (mg/dL)
44.24 ± 1.58
41.45 ± 1.37
0.18
42.2 ± 1.33
38.58 ± 1.03
0.03
LDL (mg/dL)
136.56 ± 5.85
138.31 ± 7.24
0.85
110.02 ± 6.01
133.61 ± 6.69
0.01
VLDL (mg/dL)
53.28 ± 3.05
50.44 ± 2.66
0.48
45.35 ± 2.64
49.87 ± 2.62
0.2
Serum TG (mg/dL)
272.48 ± 15.53
252.29 ± 13.23
0.32
231.88 ± 14.08
256.02 ± 13.4
0.2
SD: standard deviation; HDL: high-density lipoprotein; LDL: low-density lipoprotein; VLDL: very-low-density lipoprotein; TG: triglyceride; mg/dl: milligram per deciliter.
